China Resources Group (Group)

CR-CP Life Science Fund is a venture capital fund jointly sponsored by China Resources Group (“CR”) and Charoen Pokphand Group (“CP”) with initial AUM of $300 million contributed by CR, CP and other global life science investors. The Fund invests in leading life science companies that develop innovative drugs, cell therapies, medical devices and smart healthcare technologies. *

	Start	2020-09-30 existent
	Industry	finance
	Industry 2	LIFE SCIENCES


Basic data	Employees	n. a.

		* Document for »About Section«: ReViral Ltd.. (8/25/20). "Press Release: ReViral Raises $44 Million in Series C Financing". London & Research Triangle Park, NC.

		Record changed: 2022-04-10

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

More documents for China Resources Group (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]